Advisory Committee
The Accelerating Cancer Cures Advisory Committee is comprised of senior oncology leaders in the collaborating companies. A valuable resource for Damon Runyon scientists, committee members are available for discussions and advice about the process of translating discoveries into therapeutics.
I-Fen Chang, PharmD
VP, Global Medical Oncology TA Head Amgen, Inc.
Jennifer Lauchle, MD
Global Head of Translational Clinical Oncology Novartis
H. Michael Shepard, PhD
Biooncology, LLC
Professor, Shanghai Jiao Tong University, Shanghai,
China and Adjunct Professor, Department of Biological Sciences, Indiana University,
Bloomington, IN
Alex Shoemaker, PhD
Vice President of Oncology Discovery
AbbVie
